Interest Paid, Excluding Capitalized Interest, Operating Activities in USD of IGC Pharma, Inc. from 2017 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
IGC Pharma, Inc. quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and change rate from 2017 to Q2 2025.
- IGC Pharma, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 30 Jun 2025 was $1,000, unchanged year-over-year.
- IGC Pharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $0.
- IGC Pharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $0, a 100% decline from 2019.
- IGC Pharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2019 was $8,000, a 42.9% decline from 2018.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)